The European Medicines Agency (EMA) has announced that it has started the evaluation of an application from BioNTech/Pfizer for a booster dose of the Comirnaty vaccine against COVID-19 in adolescents aged 12 to 15 years.
As noted in the announcement, an evaluation of a separate application concerning the booster dose in adolescents aged 16 to 17 years is already underway.
Recall that a booster dose of this vaccine, i.e. a third dose after completion of the initial vaccination regimen to restore protection after it has weakened over time, has already been approved for persons over 18 years of age.
(CNA)
CNA - Giorgos Kakouris
Contents of this article including associated images are owned by CNA
Views & opinions expressed are those of the author and/or CNA
Source
